Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Borg

Showing results (151-160 of 224) with videos related to

Pageof 23
Sort By:
JAMA Oncology|November 14, 2018
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical TrialJaafar Bennouna, Sandrine Hiret, Aurelie Bertaut, et al.
Cells|December 20, 2018
<i>ATG9A</i> Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer PhenotypesAurore Claude-Taupin, Leïla Fonderflick, Thierry Gauthier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy responseYann Godet, Elizabeth Fabre, Magalie Dosset, et al.
World Journal of Clinical Oncology|September 27, 2018
FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancerCandice Carola, François Ghiringhelli, Stefano Kim, et al.
Scientific Reports|March 8, 2022
Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by ImmunohistochemistryZohair Selmani, Chloé Molimard, Alexis Overs, et al.
Immunity|March 13, 2012
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expressionFanny Chalmin, Grégoire Mignot, Mélanie Bruchard, et al.
Oncotarget|April 22, 2017
Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic miceLaurie Rangan, Jeanne Galaine, Romain Boidot, et al.
Cell Reports. Medicine|June 21, 2025
UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunityCaroline Laheurte, Laura Boullerot, Babacar Ndao, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2012
CD4 lymphopenia to identify end-of-life metastatic cancer patientsJulien Péron, Claire Cropet, Olivier Tredan, et al.
Blood|January 22, 2010
Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistanceCarole Henry, Marina Deschamps, Pierre-Simon Rohrlich, et al.
Pageof 23

Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
JAMA Oncology|November 14, 2018
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical TrialJaafar Bennouna, Sandrine Hiret, Aurelie Bertaut, et al.
Cells|December 20, 2018
<i>ATG9A</i> Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer PhenotypesAurore Claude-Taupin, Leïla Fonderflick, Thierry Gauthier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy responseYann Godet, Elizabeth Fabre, Magalie Dosset, et al.
World Journal of Clinical Oncology|September 27, 2018
FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancerCandice Carola, François Ghiringhelli, Stefano Kim, et al.
Scientific Reports|March 8, 2022
Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by ImmunohistochemistryZohair Selmani, Chloé Molimard, Alexis Overs, et al.
Immunity|March 13, 2012
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expressionFanny Chalmin, Grégoire Mignot, Mélanie Bruchard, et al.
Oncotarget|April 22, 2017
Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic miceLaurie Rangan, Jeanne Galaine, Romain Boidot, et al.
Cell Reports. Medicine|June 21, 2025
UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunityCaroline Laheurte, Laura Boullerot, Babacar Ndao, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2012
CD4 lymphopenia to identify end-of-life metastatic cancer patientsJulien Péron, Claire Cropet, Olivier Tredan, et al.
Blood|January 22, 2010
Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistanceCarole Henry, Marina Deschamps, Pierre-Simon Rohrlich, et al.
Pageof 23